We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Interventional Microcatheter Navigates Narrow Vasculature

By HospiMedica International staff writers
Posted on 15 May 2012
A new catheter is designed for use in small vessels and superselective anatomy during diagnostic and interventional procedures in the peripheral vasculature. More...


The Embarc Microcatheter has an engineered tapered transition that offers proximal advancement with distal flexibility, allowing navigation during super-selective procedures in the tortuous anatomy of the peripheral vasculature. Other features include a kink resistant shaft and an extruded polytetrafluoroethylene (PTFE) liner that provides for a smooth guidewire and embolic interface, assisted by GLYCE, an ultra-durable hydrophilic-coated outer surface that increases trackability and enhances vessel navigation.

A multiple-layer platinum/iridium and stainless steel braided shaft provides enhanced visibility under fluoroscopy and optimal catheter stability in embolic delivery, as well as allowing a 6,894 kPa power injection pressure. An inner-coiled strain relief allows for improved kink resistance, with a unique hub design with contoured wings that gives precise catheter control, and facilitates smooth delivery and confirmation of embolic material and chemotherapeutic agents. A formed distal tip improves trackability and atraumatic vessel selection. The Embarc Microcatheter is a product of Navilyst Medical (Marlborough, MA, USA)
.
“The peripheral embolization space is an exciting and growing area offering the opportunity for improved outcomes across a wide range of procedures, many of which once required surgery and can now be treated less invasively with less risk, pain, and recovery time for the patient,” said Ron Sparks, chairman and CEO of Navilyst Medical. “Continuing to make advancements in the devices used by interventional radiologists, in what is expected to surpass 140,000 procedures this year alone, is a critical part of improving patient outcomes.”


Related Links:

Navilyst Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.